Huntington’s disease: Neuropsychiatric manifestations of Huntington’s disease
- 16 July 2018
- journal article
- research article
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 26 (4) , 366-375
Abstract
Objectives: Huntington’s disease (HD) is a profoundly incapacitating, and ultimately fatal, neurodegenerative disease. HD is presently incurable, so the current goal is to allow affected individuals to live as well as possible with the illness, to maximise functional independence and quality of life for the person with HD, their carers and family members. This clinical update review focuses on the common neuropsychiatric manifestations in HD, and outlines and evaluates the various neuropsychiatric facets of HD, including the aetiology, symptoms and diagnosis. Conclusions: Neuropsychiatric symptoms can precede the classic motor clinical symptoms of HD (prodromal HD) by decades, and cause significant functional impairment. HD provides key insights and understanding into the organic psychiatric disorders, including contemporary clinical insights into the process of neurodegeneration and manifestation of neuropsychiatric symptoms.Keywords
This publication has 21 references indexed in Scilit:
- Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson DiseaseJAMA Neurology, 2013
- Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflectionsHuman Reproduction Update, 2013
- Perception, Experience, and Response to Genetic Discrimination in Huntington's Disease: The Australian Results of the International RESPOND-HD StudyGenetic Testing and Molecular Biomarkers, 2013
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational dataThe Lancet Neurology, 2012
- Cognitive Impairment in Huntington Disease: Diagnosis and TreatmentCurrent Neurology and Neuroscience Reports, 2011
- Distinct Brain Volume Changes Correlating with Clinical Stage, Disease Progression Rate, Mutation Size, and Age at Onset Prediction as Early Biomarkers of Brain Atrophy in Huntington's DiseaseCNS Neuroscience & Therapeutics, 2009
- Mechanisms of neurodegeneration in Huntington’s diseaseEuropean Journal of Neuroscience, 2008
- Effect of CAG repeat length on psychiatric disorders in Huntington’s diseaseJournal of Psychiatric Research, 2008
- Neuropsychiatric aspects of Huntington's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2001
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993